Creative Medical Technology Holdings, Inc.: 10-K filed 2013-03-15
What Creative Medical Technology Holdings, Inc. reported in its annual report filed 2013-03-15 (fiscal FY 2012): 21 published measures, 44 facts as tagged in accession 0001078782-13-000455.
This filing
- Form
- 10-K (annual report)
- Filed
- 2013-03-15
- Fiscal period
- fiscal FY 2012
- Accession
- 0001078782-13-000455 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Creative Medical Technology Holdings, Inc. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 1,568 | USD | |
| At 2011-12-31 | 3,105 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-03 | 781 | USD | |
| At 2011-12-31 | 1,105 | USD | |
| At 2011-12-03 | 1,105 | USD | |
| At 2010-12-31 | 414 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | -25,585 | USD | 366 |
| 2011-01-01 to 2011-12-31 | -24,055 | USD | 365 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-12-04 to 2012-12-03 | -16,774 | USD | 366 |
| 2011-01-01 to 2011-12-31 | -13,959 | USD | 365 |
Financing cash flow
Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-12-04 to 2012-12-03 | 16,450 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 14,650 | USD | 365 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-12-04 to 2012-12-03 | 0 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 0 | USD | 365 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | -270,044 | USD | |
| At 2011-12-31 | -244,459 | USD |
Diluted weighted-average shares
Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 18,113,750 | shares | 366 |
| 2011-01-01 to 2011-12-31 | 18,113,750 | shares | 365 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | -20,096 | USD | 366 |
| 2011-01-01 to 2011-12-31 | -19,830 | USD | 365 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 1,568 | USD | |
| At 2011-12-31 | 3,105 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 99,317 | USD | |
| At 2011-12-31 | 75,269 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 9,980 | USD | |
| At 2011-12-31 | 7,871 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 20,096 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 19,830 | USD | 365 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 18,113,750 | shares | |
| At 2011-12-31 | 18,113,750 | shares |
Additional paid-in capital
Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 154,181 | USD | |
| At 2011-12-31 | 154,181 | USD |
Total equity including noncontrolling interests
Equity including the portion attributable to noncontrolling interests. It is larger than or equal to parent stockholders equity and is not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | -97,749 | USD | |
| At 2011-12-31 | -72,164 | USD |
Net deferred tax assets
Deferred tax assets after the valuation allowance. Realization depends on future taxable income, so the balance is not a receivable from tax authorities.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2012-12-31 | 0 | USD | |
| At 2011-12-31 | 0 | USD |
Profit or loss including noncontrolling interests
Net income or loss including the portion attributable to noncontrolling interests. It can differ from the net income attributable to the parent that per-share figures use.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-12-04 to 2012-12-03 | -25,585 | USD | 366 |
| 2011-01-01 to 2011-12-31 | -24,055 | USD | 365 |
Current income tax expense or benefit
Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 0 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 0 | USD | 365 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2012-01-01 to 2012-12-31 | 0 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 0 | USD | 365 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-12-04 to 2012-12-03 | 2,109 | USD | 366 |
| 2011-01-01 to 2011-12-31 | 7,871 | USD | 365 |
Inspect the source
- Entity
- Creative Medical Technology Holdings, Inc. / CIK 0001187953
- Captured
- 2026-09-20T07:45:17.099Z
- SEC response SHA-256
89e881c0f2d97477b4adfc3e19e7ae581dc54b90e3254331c852038e8d4c6961
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001187953.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))